Get the Stockscreener App
7.02
0.71%
-0.05
Pre-market:
7.10
0.08
+1.14%
Alpha Tau Medical Ltd stock is traded at $7.02, with a volume of 559.67K.
It is down -0.71% in the last 24 hours and down -7.63% over the past month.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
See More
Previous Close:
$7.07
Open:
$6.78
24h Volume:
559.67K
Relative Volume:
1.71
Market Cap:
$598.55M
Revenue:
-
Net Income/Loss:
$-29.64M
P/E Ratio:
-16.33
EPS:
-0.43
Net Cash Flow:
$-39.43M
1W Performance:
-16.63%
1M Performance:
-7.63%
6M Performance:
+101.15%
1Y Performance:
+145.45%
1-Day Range:
$6.30
$7.05
1-Week Range:
$6.30
$8.40
52-Week Range:
$2.30
$8.60
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Compare DRTS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
7.02 | 602.82M | 0 | -29.64M | -39.43M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-23 | Initiated | Citigroup | Buy |
| Apr-24-23 | Initiated | H.C. Wainwright | Buy |
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-22 | Initiated | Piper Sandler | Overweight |
| Apr-04-22 | Initiated | Citigroup | Buy |
Alpha Tau Medical Ltd Stock (DRTS) Latest News
Alpha Tau Medical Shares Fall After Piper Sandler Downgrade - marketscreener.com
Piper Sandler cuts Alpha Tau Medical stock rating on valuation - Investing.com South Africa
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Piper Sandler Reiterates Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
DRTS Receives Downgrade from Piper Sandler with Neutral Rating | - GuruFocus
Piper Sandler cuts Alpha Tau Medical stock rating on valuation By Investing.com - Investing.com Canada
Alpha Tau Medical (DRTS) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Is Alpha Tau Medical Ltd. Equity Warrant benefiting from interest rate changes2025 Key Lessons & Long-Term Growth Portfolio Plans - mfd.ru
DRTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 6.89% Upside in Innovative Cancer Treatment Technology - DirectorsTalk Interviews
Alpha Tau Medical (DRTSW) to Release Earnings on Thursday - Defense World
DRTS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighWhat's Next? - MarketBeat
H.C. Wainwright raises Alpha Tau Medical price target on Japan approval - Investing.com Nigeria
Shorts Report: Will Alpha Tau Medical Ltd benefit from rate cutsJuly 2025 Rallies & Daily Momentum Trading Reports - baoquankhu1.vn
Alpha Tau price target raised to $12 from $9 at H.C. Wainwright - Yahoo Finance
Alpha Tau Lands First International Approval as Japan Grants Mar - GuruFocus
Alpha Tau Lands First International Approval as Japan Grants Marketing Clearance for Alpha DaRT (NASDAQ: DRTS) - TipRanks
H.C. Wainwright Maintained Buy on Alpha Tau Medical Ltd. (DRTS) Feb 2026 - Meyka
HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT - Business Wire
Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy - TipRanks
Alpha Tau Medical receives Japanese marketing approval for Alpha Dart in head and neck cancer - marketscreener.com
Japan grants Shonin approval for Alpha Tau (DRTS) Alpha DaRT cancer therapy - Stock Titan
Alpha Tau Medical Receives Japanese Marketing Approval for - GlobeNewswire
Alpha Tau Medical (DRTSW) Stock Analysis Report | Financials & Insights - Benzinga España
CEO Change: Will MPLX benefit from seasonalityPortfolio Gains Summary & Consistent Growth Equity Picks - baoquankhu1.vn
Risk Off: What is FORLUs valuation compared to sectorPortfolio Value Summary & Risk Controlled Stock Alerts - baoquankhu1.vn
Retail Trends: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demand2025 Price Momentum & Fast Gain Stock Tips - baoquankhu1.vn
Macro Review: Will Plumas Bancorp benefit from rising consumer demandJuly 2025 Outlook & Reliable Price Action Trade Plans - baoquankhu1.vn
Aug PreEarnings: Can Alpha Tau Medical Ltd sustain its profitabilityJuly 2025 Big Picture & AI Forecasted Stock Moves - baoquankhu1.vn
Lucid Diagnostics (NASDAQ:LUCD) & Alpha Tau Medical (NASDAQ:DRTS) Financial Survey - Defense World
Support Test: Should I invest in Alpha Tau Medical Ltd. before earningsPortfolio Performance Report & Fast Gain Stock Trading Tips - mfd.ru
Alpha Tau Medical (NASDAQ:DRTS) Upgraded at Zacks Research - Defense World
Alpha Tau Medical (NASDAQ:DRTSW) Trading Down 2.2% – Should You Sell? - Defense World
VIX Spike: Is Alpha Tau Medical Ltd Equity Warrant in a bullish channelInsider Buying & Accurate Buy Signal Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd. Equity Warrant stock overvalued or fairly priced2025 Market Overview & Safe Capital Preservation Plans - mfd.ru
Is Alpha Tau Medical Ltd. Equity Warrant stock a good pick for beginners2025 Stock Rankings & Real-Time Market Sentiment Reports - mfd.ru
What hedge fund activity signals for Alpha Tau Medical Ltd. stock2025 Short Interest & Accurate Entry and Exit Point Alerts - mfd.ru
Big Picture: What is the Moat Score of Alpha Tau Medical Ltd.Trade Risk Report & Free Risk Controlled Daily Trade Plans - mfd.ru
Can Alpha Tau Medical Ltd. Equity Warrant reach all time highs this yearDip Buying & AI Powered Buy/Sell Recommendations - mfd.ru
Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Unveiling a 10.74% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
Should you buy the dip on Alpha Tau Medical Ltd. Equity WarrantPortfolio Profit Report & Consistent Profit Alerts - mfd.ru
What’s next for Alpha Tau Medical Ltd. stockQuarterly Earnings Report & Consistent Income Trade Recommendations - mfd.ru
Alpha Tau Medical (NASDAQ:DRTS) Shares Down 6.6%Here's What Happened - MarketBeat
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛
Energy Moves: How does Alpha Tau Medical Ltd compare to its peersOptions Play & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Alpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026 - MSN
IPO Launch: Is Alpha Tau Medical Ltd stock showing strong momentumQuarterly Profit Review & Capital Protection Trading Alerts - baoquankhu1.vn
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Large Increase in Short Interest - Defense World
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Rises By 111.0% - MarketBeat
DRTSWAlpha Tau Medical Ltd Latest Stock News & Market Updates - Stock Titan
Alpha Tau Medical Ltd Stock (DRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
6.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):